FE Trustnet's Joshua Ausden asks whether discount control mechanisms (DCMs) are really all they are cracked up to be.
Economic data from US and UK not strong enough
Neil Woodford's Patient Capital Trust is to issue new shares in a tap issuance programme to satisfy 'excess demand' from investors.
Vestra Wealth has hired Russell Harrop, formerly Woodford Investment Management, as head of international equities.
Broker Stifel has recommended investors sell Neil Woodford's Patient Capital trust due to its share price trading at a high premium to NAV.
The fund groups with the best Twitter strategies
The Patient Capital investment trust is to enter the FTSE 250 later this month, two months on from its record fundraising.
Fund managers give their views on the key issues impacting global asset classes and outline how they are positioning portfolios.